The REVERT Maneuver: Modified Valsalva for Paroxysmal SVT
30 seconds of the right positioning does what others reach for a needle of adenosine to achieve — and works 2.5 times better than the classic maneuver most of us learned in training.
We’re opening a new series, Micro-Interventions — short, hands-on procedures and maneuvers you can apply immediately in the field. The first installment is the REVERT maneuver, a postural modification of the classic Valsalva maneuver that significantly increases the chance of converting paroxysmal supraventricular tachycardia (SVT) to sinus rhythm, without drugs and without risk.
Why vagal maneuvers still matter in the age of adenosine
Vagal maneuvers have been the recommended first step in treating paroxysmal SVT for decades, across every relevant guideline including ERC. Their main advantage is zero risk of pharmacological side effects — adenosine works reliably, but typically triggers a few seconds of impending doom, flushing, and transient asystole. The classic Valsalva maneuver, however, has disappointingly low real-world efficacy — conversion to sinus rhythm ranges only between 5 and 20%.
Dispatched to a patient with sudden-onset palpitations starting 20 minutes ago, no chest pain, no dyspnea. BP 118/76, SpO₂ 98%, ECG monitor shows a narrow-complex regular tachycardia at 182/min. Patient conscious, oriented, hemodynamically stable.
Decision: before adenosine or electrical cardioversion, a stable patient should first receive a vagal maneuver — specifically its modified (REVERT) form.
Clinical indication
A hemodynamically stable patient with paroxysmal supraventricular tachycardia (narrow-complex, regular tachyarrhythmia, typically AVNRT or AVRT) — as first-line intervention before pharmacological cardioversion.
Contraindications and limitations
A hemodynamically unstable patient (hypotension, altered consciousness, signs of shock, pulmonary edema) — proceed directly per the unstable tachycardia algorithm. Also use caution in acute coronary syndrome, severe aortic stenosis, recent myocardial infarction, glaucoma, and pregnancy with hemodynamic instability.
Step-by-step procedure
REVERT vs. classic Valsalva
Produces vagal stimulation only during the straining phase. Simple to perform, but disappointingly low and unreliable efficacy in real-world practice.
Adds a second phase — immediately lying flat with legs elevated, which increases venous return and deepens vagal stimulation of the AV node at the moment it is most sensitive. NNT = 4, with no increase in serious adverse events.
Physiological background
The standard Valsalva maneuver produces vagal stimulation mainly during the straining phase, when increased intrathoracic pressure transiently reduces venous return. The REVERT modification adds a second phase — immediately lying flat with legs elevated — which substantially increases venous return and secondarily deepens vagal stimulation of the AV node. This second phase, not the exhale itself, is the main reason for its markedly higher efficacy over the classic maneuver.
Common field mistakes
| Mistake | Consequence |
|---|---|
| Insufficient exhale pressure (below 40 mmHg) | ↓ efficacy |
| Delayed repositioning after exhale | loses phase-2 effect |
| No continuous ECG recording during the maneuver | cannot verify outcome |
| Maneuver performed on an unstable patient | delays cardioversion |
| Using the syringe without instructing the patient | pressure target missed |
Documenting the procedure
“We tried the maneuver, it worked.”
“REVERT maneuver performed (modified Valsalva) — 40 mmHg exhale for 15 s semi-recumbent, followed by supine repositioning with leg elevation for 15 s. Conversion to sinus rhythm after one attempt, confirmed on ECG. BP and SpO₂ within normal limits, no adverse events.”
“Didn’t work, so we gave the drug.”
“REVERT maneuver performed twice without rhythm conversion; patient hemodynamically stable throughout. Adenosine subsequently administered per medical direction, conversion to sinus rhythm confirmed on ECG.”
Practical takeaways for the responder
1. The REVERT maneuver is first-line therapy for a stable patient with paroxysmal SVT — use it before adenosine.
2. Sequence: 15 s exhale at 40 mmHg semi-recumbent → immediately flat with legs elevated for 15 s.
3. Conversion to sinus rhythm around 43% vs. 17% for the classic Valsalva maneuver, NNT 4.
4. If unsuccessful after 1–2 attempts, pharmacological cardioversion follows per medical direction.
- REVERT Maneuver for Paroxysmal SVT (this article)
- Intraosseous Access with EZ-IO
- Celox Hemostatic Gauze for Junctional Hemorrhage
- Needle Decompression of Tension Pneumothorax
- Airway-Opening Maneuvers
- Nasopharyngeal Airway
- Applying the CAT Tourniquet
- Manual In-Line Cervical Spine Stabilization During Extrication
- Head and Cervical Spine Fixation on a Vacuum Mattress
- Peripheral IV Cannulation in the Centralized Patient
- Applying a Chest Seal for Open Pneumothorax
- Appelboam A, Reuben A, Mann C, et al. Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial. Lancet. 2015;386(10005):1747–1753.
- European Resuscitation Council Guidelines 2021 — Adult Advanced Life Support, tachycardia algorithm.
- Smith GD, Boyle MJ. The 10 mL syringe is useful in generating the recommended standard of 40 mmHg intrathoracic pressure for the Valsalva manoeuvre. Emerg Med Australas. 2009;21(6):449–454.
- Smith GD, Fry MM, Taylor D, Morgans A, Cantwell K. Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia. Cochrane Database Syst Rev. 2015.